: Transcatheter Aortic Valve Implantation (TAVI) Market Report – Procedures and Opportunities 2014–2022

Allied Market Research has recently published an in-depth study of the global transcatheter aortic valve implantation market, which is a comprehensive study of the industry for the period 2014–2022. The report includes vital statistics and industry insights on the different aspects, such as market share, size, growth, potential, and dynamics for the given forecast period. It considers the different procedures that are included in the TAVI therapies, along with a comprehensive understanding of the various government regulations that oversee the approval of the same.

Sample of the research: https://goo.gl/L11Nbn

Experts writing this report predict that the market is expected to garner a huge sum of $5,962 billion by 2020. This is expected to be met by a CAGR of 16.5% during the given forecast period.

The TAVI market report opens with a basic introduction to the market. It describes the key benefits of the report and how its findings can aid in better decision-making for the interested stakeholders. The key market segments have been outlined in the study. Raw data collected from primary and secondary research inputs sources give accurate insights and look into the functioning of the industry. The transcatheter aortic valve is systematically studied and a detailed analysis of the same has been included in the report. This includes Porter’s Five Forces analysis as well as a close scrutiny of the market shares in the period 2014–2022. The top investment pockets are highlighted to enable stakeholders understand the diverse potential posed by each procedure after clearing clinical trials.

The study highlights the segments of the market, especially the diverse procedures. The growing need for artificial valve implantation through minimal anesthesia has popularized the procedure of transfemoral implantation. The report explains that this procedure accounts for the highest market share in 2015. In the next few years, the transaortic procedures and transapical TAVI are expected to earn major revenues for the entire market. In terms of volume, the transaortic segment is projected to exhibit a CAGR of 23.9% during the next few years, owing to the success of several clinical trials.
The report segments the TAVI market based on the procedure used for implantation. The three basic types of procedures used for implantation include the transfemoral, transapical, and transaortic implantation. Transfemoral implantation appears the most standardized TAVI procedure, wherein an artificial valve is implanted through the femoral artery. The treatment is not feasible for patients with weak and small arteries. This is one reason why the transapical implantation procedure has gained more approval, as it involves the insertion of the artificial valve through the left ventricular apex. Moreover, the transaortic implantation is designed for patients who possess weak femoral arteries and have weak respiratory functions. This has directly augmented the growth of the transaortic procedure segment which points towards a significant growth in the next few years.

The transcatheter aortic valve implantation market examines the market presence in various regions of the world. A comprehensive understanding of the various procedures and their growth prospects in various regions of the world helps understand investors about market potential in various geographical regions. The potential investment pockets and the market scope n the regions of North America, Europe, Asia-Pacific, and LAMEA are outlined in the report. While Mexico has an exponential growth in the North American region, Germany and UK also have promising potential growth in the entire Europe market. Asia-Pacific is expected to be the most lucrative in the immediate future.

Full summary: https://www.alliedmarketresearch.com/tavi-market

Key findings:

• The TAVI report explains that the transaortic segment is expected to exhibit the highest CAGR of 22.7% (in terms of value) and 23.9% (in terms of volume) by 2022, attributed to the positive outcomes of several clinical trials.
• The segment of transfemoral procedures was the highest revenue-generating area in 2015. In terms of value, the CAGR of 16.0% is expected to be the growth rate for the given forecast period.
• In the Asia-Pacific region, developing nations especially India is expected to be the fastest growing country, with an estimated CAGR of 34.7% when it comes to revenue generation.
• The market in the European region is led by Germany, whereas UK is projected to be the fastest-growing industry.
Key industry profiles enlisted in the TAVI market report include names, such as Medtronic plc, St. Jude Medical, Inc., Edwards Lifesciences Corporation, HLT, Inc., Direct Flow Medical, Inc., Meril Life Sciences Pvt. Ltd., and Boston Scientific Corporation. The report gives a detailed overview of each company engaged in the industry, along with their product offerings and operating business segments. The key strategic moves and dynamics followed by each player have also been documented in the study to enable a clear, competitive analysis of the market for a better understanding of the market trends.

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions". AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Direct: +1-503-894-6022
Toll Free: +1 (800) 792-5285 (U.S. & Canada)
Fax: +1 (855) 550-5975
E-mail: sales@alliedmarketresearch.com

This release was published on openPR.